欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0487/004
药品名称
Olanzapina Aurobindo
活性成分
olanzapine 10.0 mg
剂型
Tablet
上市许可持有人
Aurobindo Pharma (Malta) Ltd, Malta
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Finland (FI)
Cyprus (CY)
Malta (MT)
Olanzapine Tablets 10mg
Germany (DE)
Olanzapin Aurobindo 10 mg, Tabletten
Netherlands (NL)
Italy (IT)
Romania (RO)
Olanzapina Aurobindo 10 mg comprimate
Lithuania (LT)
Olanzapine Aurobindo 10 mg tabletės
Belgium (BE)
许可日期
2011/11/03
最近更新日期
2024/08/09
药物ATC编码
N05AH03 olanzapine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
52532_52533_52535_52538_52539_20120217_52540_PAR_JLE
Date of last change:2024/09/06
Final Product Information
|
52550_52552_52555_52556_52557_52558_20120217_PAR_JLE
Date of last change:2024/09/06
Final PL
|
common_pl
Date of last change:2024/09/06
Final SPC
|
common_spc
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase